First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

We'd like our readers to start paying for Daily Maverick

More specifically, we'd like those who can afford to pay to start paying. What it comes down to is whether or not you value Daily Maverick. Think of us in terms of your daily cappuccino from your favourite coffee shop. It costs around R35. That’s R1,050 per month on frothy milk. Don’t get us wrong, we’re almost exclusively fuelled by coffee. BUT maybe R200 of that R1,050 could go to the journalism that’s fighting for the country?

We don’t dictate how much we’d like our readers to contribute. After all, how much you value our work is subjective (and frankly, every amount helps). At R200, you get it back in Uber Eats and ride vouchers every month, but that’s just a suggestion. A little less than a week’s worth of cappuccinos.

We can't survive on hope and our own determination. Our country is going to be considerably worse off if we don’t have a strong, sustainable news media. If you’re rejigging your budgets, and it comes to choosing between frothy milk and Daily Maverick, we hope you might reconsider that cappuccino.

We need your help. And we’re not ashamed to ask for it.

Our mission is to Defend Truth. Join Maverick Insider.

Support Daily Maverick→
Payment options

Colin Powell’s Death From Breakthrough Covid Is Rare...

Newsdeck

Breakthrough Infection

Colin Powell’s Death From Breakthrough Covid Is Rare Event, Data Show

Colin Powell. Image: Supplied colin powell
By Bloomberg
18 Oct 2021 0

The death of former U.S. Secretary of State Colin Powell following a breakthrough Covid-19 infection shines a high-profile spotlight on what has been a rare phenomenon. 

By Emma Court

Word Count: 540
(Bloomberg) — 

Powell died at age 84 from Covid-19 complications despite being fully vaccinated, his family announced on Monday. A decorated former general and chairman of the Joint Chiefs of Staff, he was being treated at the Walter Reed National Medical Center.

Powell, who previously underwent surgery for prostate cancer in 2003, had been diagnosed with multiple myeloma prior to falling ill with Covid-19.

The available data show that such deaths are exceptionally rare. Out of the more than 187 million people who had been fully vaccinated in the U.S. as of Oct. 12, 7,178, or 0.004%, had died from a breakthrough infection, according to the U.S. Centers for Disease Control and Prevention. Of that group, 85% were over the age of 65.

Read More: Colin Powell, Army General Turned Top Diplomat, Dies at 84

People who come down with Covid-19 after getting vaccinated are also unlikely to wind up in the hospital, the data suggest. Through Oct. 12, 24,717 people had been hospitalized with a breakthrough case, and of that group, 67% were 65 or older.

The numbers reinforce results from the clinical trials of Covid-19 vaccines and booster shots that showed that getting inoculated substantially reduces the odds that a recipient will become sick enough to require hospitalization or die if they do become infected.

Older adults who contract breakthrough infections do appear to be at higher risk of more serious outcomes, and having a condition like cancer can add further risk, said Josh Michaud, associate director, global health policy at the Kaiser Family Foundation.

“Colin Powell, 84 years old, fits that profile,” he said. “Older adults have a greater risk that the infection will progress to a more severe stage, and some will progress all the way to death, unfortunately,” while having multiple myeloma may have hampered Powell’s ability to fend off a Covid-19 infection.

Multiple myeloma is a type of blood cancer and is considered rare. Powell shared his diagnosis at a 2019 event hosted by the Multiple Myeloma Research Foundation intended to focus on his experience with prostate cancer, founder Kathy Giusti said in a statement. He had been getting treatment for the cancer and “seemed to be responding well,” she said.

“Immunosuppression is a well-known side effect of cancer treatment and a reminder that as patients, we are at high risk, especially if also over 65 years of age,” said Giusti.

Older Americans and those with medical conditions like cancer are among those eligible for a booster dose of the Pfizer Inc.-BioNTech SE shot in the U.S. The Food and Drug Administration could authorize boosters for Americans who received the Moderna Inc. and Johnson & Johnson vaccines as soon as this week.

Powell was supposed to get a booster shot last week but became sick and was unable to, a spokeswoman told the New York Times. Representatives of the Powell family couldn’t be reached for comment.

This “might serve as a reminder for those adults who are eligible for boosters but have not yet received one to go out and get one,” Michaud said. “Perhaps this jars people into action.”

Gallery

Comments - share your knowledge and experience

Please note you must be a Maverick Insider to comment. Sign up here or sign in if you are already an Insider.

Everybody has an opinion but not everyone has the knowledge and the experience to contribute meaningfully to a discussion. That’s what we want from our members. Help us learn with your expertise and insights on articles that we publish. We encourage different, respectful viewpoints to further our understanding of the world. View our comments policy here.

No Comments, yet

Please peer review 3 community comments before your comment can be posted